Insights

Missouri’s Cannabis Microbusiness License Program Under Scrutiny Amid Ineligibility and Exploitation Concerns

NEW YORK– Missouri's well-intentioned microbusiness license program, designed to foster diversity and inclusion in the burgeoning cannabis industry, is now facing significant scrutiny. Recent findings have revealed a disturbing trend of ineligible applicants receiving licenses, and out-of-state companies exploiting the system, casting a shadow over the program's integrity and fairness. Established in November 2022 as ...

December 27th, 2023|

Massachusetts Eases ‘Two Agent Rule’ for Cannabis Deliveries, Boosting Industry Efficiency

LOS ANGELES- In a significant development for the cannabis industry in Massachusetts, the state's Cannabis Control Commission (CCC) has voted to amend the longstanding "Two Agent Rule" for cannabis deliveries. This decision marks a pivotal change for delivery companies in the state, reducing operational costs and increasing efficiency. The "Two Agent Rule," which mandated two ...

December 26th, 2023|

Global Recreational Cannabis Market on Track to Reach $50 Billion by 2027, Report Finds

LOS ANGELES- In a significant development for the global cannabis industry, a recent report from Prohibition Partners, a leading U.K.-based cannabis data, media, and technology firm, projects a dramatic expansion in the worldwide market for legal adult-use cannabis. The report estimates that by 2027, global sales will nearly double, reaching around $50 billion, driven largely ...

December 26th, 2023|

Revive Therapeutics Ltd. Announces Key Decisions and Appointments at Annual Shareholders Meeting

LOS ANGELES- Revive Therapeutics Ltd., a specialty life sciences company, held its annual general and special meeting of shareholders on Tuesday, December 19, 2023, in Toronto, Ontario. The meeting concluded with significant decisions affecting the company's future trajectory. Unanimous Support for Key Resolutions During the meeting, shareholders overwhelmingly supported all the proposals outlined in the ...

December 26th, 2023|

Decade of Discovery, Cannabis Studies Amid Legalization

NEW YORK— A significant surge in scientific research related to cannabis has been noted in the past ten years, coinciding with widespread legalization movements across the United States. This trend was highlighted by NORML, a cannabis advocacy group, which reported an extraordinary increase in the volume of peer-reviewed scientific papers on the subject. According to ...

December 25th, 2023|

Incannex’s Subsidiary Clarion Clinics Gains Ethics Endorsement for Psychedelic-Assisted Therapies

LOS ANGELES- Incannex Healthcare Ltd  a clinical stage pharmaceutical development company, has announced a significant advancement in the field of psychedelic-assisted therapies. Its subsidiary, Clarion Clinics, received Human Research Ethics Committee (HREC) endorsement for administering psychedelic-assisted therapies for Treatment Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD). This approval marks a critical step in legitimizing ...

December 25th, 2023|

Mydecine Innovations Group Announces Major Patent Progress for Novel Psilocin Analog

LOS ANGELES-  Mydecine Innovations Group Inc, a biotechnology company in mental health and addiction treatment, has recently announced a significant breakthrough. The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's MYCO-005 compound, titled “Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same Unique Compound (US20230348380A1)”. This ...

December 25th, 2023|
  • Recreational Cannabis

Colorado Voter Initiative Challenges Federal Law on Cannabis Users’ Gun Rights

LOS ANGELES- A new voter initiative in Colorado is stirring up a significant debate over the intersection of cannabis legalization and gun rights. The proposal, spearheaded by the pro-gun advocacy group Guns for Everyone, aims to allow cannabis consumers to qualify for concealed carry firearm permits, challenging the current restrictions imposed by federal law. Under ...

December 22nd, 2023|

Controversy Arises Over Ohio’s New Cannabis Control Superintendent Appointment

LOS ANGELES- Ohio's recent strides towards cannabis legalization have been met with a mix of anticipation and concern, particularly following the appointment of James V. Canepa as the first Superintendent of the Division of Cannabis Control. This decision has sparked debate among industry experts, activists, and the public, raising questions about the state's commitment to progressive ...

December 22nd, 2023|

Minnesota Health Officials Caution Against Illegal High-Potency Hemp Products

LOS ANGELES- The Minnesota Department of Health has issued an urgent warning to consumers regarding the sale of unregulated and illegal cannabis products that exceed the state's THC potency limits. Despite legalizing recreational cannabis earlier this year, Minnesota does not expect state-licensed cannabis dispensaries to open until possibly early 2025, leaving a regulatory gap that ...

December 22nd, 2023|

California Attorney General Warns of Federal Risks in Interstate Cannabis Commerce

LOS ANGELES- California Attorney General Rob Bonta has recently raised significant concerns over the potential federal legal risks involved in initiating interstate cannabis commerce. This issue has become a pivotal point of discussion following the enactment of a law by Gov. Gavin Newsome last year, which authorized state-licensed cannabis companies to export their products to ...

December 22nd, 2023|

Psychedelics Regulatory Maze: Navigating the State-Federal Conundrum

The expanding legalization of psychedelics for medical and therapeutic uses across various states in the United States is stepping into a complex regulatory terrain, one previously charted by the cannabis industry. This emerging scenario raises critical questions about the interplay between state autonomy and federal oversight in drug regulation. The issue hinges on the divergent ...

December 20th, 2023|

Numinus and Cedar Clinical Research Join Beckley Psytech’s Phase 2b Psychedelic Trial for Depression

Numinus Wellness Inc. recognized for approach to mental health care, has announced a significant milestone in psychedelic-assisted therapies. Its research arm, Cedar Clinical Research (CCR), has been selected as a pivotal site for a groundbreaking Phase 2b clinical trial by Beckley Psytech, focusing on Treatment Resistant Depression (TRD). This study is designed to assess the ...

December 19th, 2023|

Regulatory Hurdles Challenge Social Equity Cannabis Licensing in Missouri

LOS ANGELES- In a significant development impacting Missouri's cannabis industry, nearly one-quarter of the 48 social equity cannabis microbusiness permits awarded in October have been declared ineligible by the Department of Health and Senior Services (DHSS). The 11 affected applicants, encompassing permits for nine dispensaries and two wholesalers, face the loss of their licenses. This ...

December 19th, 2023|

Nebraska Medical Cannabis Initiative Gains Momentum Amid Opposition

LOS ANGELES- In Nebraska, a significant movement is underway as the group Nebraskans for Medical Marijuana (NMM) intensifies its efforts to gather signatures for two pivotal medical cannabis legalization initiatives aimed for the 2024 ballot. This drive highlights a growing grassroots movement in the state, reflecting a broader national dialogue on cannabis legalization. To secure ...

December 19th, 2023|

MindMed Announces Promising Results from Phase 2b Trial of MM-120 for Generalized Anxiety Disorder

LOS ANGELES- Mind Medicine (MindMed) Inc, a biotech company focusing on psychedelic-inspired therapies, recently revealed encouraging topline results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in treating Generalized Anxiety Disorder (GAD). The trial's success is significant, as it met its primary endpoint with MM-120 showing statistically significant improvements in anxiety symptoms compared ...

December 18th, 2023|

Sunstone Therapies Reports Breakthrough in Psilocybin-Assisted Therapy for Cancer Patients with Depression

LOS ANGELES- Sunstone Therapies, a organization in psychedelic-assisted therapy, recently announced notable findings from its phase 2 clinical trial, published in the journal Cancer. This trial marks a significant step in understanding the potential of psilocybin, a psychedelic compound, in treating major depressive disorder (MDD) among cancer patients. The study, an open-label trial, involved administering ...

December 18th, 2023|

CSU’s Institute of Cannabis Research Invests $800,000 in Groundbreaking Studies

LOS ANGELES- The Institute of Cannabis Research (ICR) at Colorado State University (CSU), Pueblo, has announced a significant investment in cannabis research, earmarking $800,000 for six pioneering studies. This initiative, funded through the Colorado Marijuana Tax Cash Fund since 2019, underscores Colorado's commitment to advancing scientific understanding of cannabis and its impacts. These studies, conducted ...

December 18th, 2023|

Colorado’s MED Prepares for Future of Cannabis Inventory Tracking

LOS ANGELES- The Colorado Marijuana Enforcement Division (MED) is at a pivotal juncture in its oversight of the state's cannabis industry. Since the legalization of recreational cannabis in 2012, the MED has played a crucial role in ensuring compliance and safety standards, notably through the use of Radio Frequency Identification (RFID) METRC tags for inventory ...

December 17th, 2023|

Trulieve Alabama Recognized as Minority-Owned Business

LOS ANGELES- The Alabama Medical Cannabis Commission (AMCC) has recently taken a significant step forward in the development of the state's medical cannabis industry. In a pivotal move, the AMCC awarded integrated licenses to five companies, marking a crucial phase in the implementation of the medical marijuana law passed in 2021 in Alabama. This development ...

December 17th, 2023|

Cannabis Bioscience International Holdings (CBIH) Announces SEC Approval for Common Stock Sale

LOS ANGELES- Cannabis Bioscience International Holdings (CBIH), a prominent player in the cannabis bioscience sector, announced on Friday a significant milestone in its financial journey. The company's registration statement on Form S-1, under the Securities Act of 1933, was declared effective by the United States Securities and Exchange Commission (SEC) on December 5. This pivotal ...

December 15th, 2023|

Beckley Academy Strengthens Psychedelic Therapy Training Team with New Facilitators

LOS ANGELES- Beckley Academy, a prominent training organization specializing in the preparation of mental health professionals for psychedelic therapies, has announced the addition of two new facilitators to their team, Sara Gael Beauregard and Mary Sanders. Both bring a wealth of experience and expertise in psychedelic therapy, significantly enhancing the academy's capacity to train practitioners ...

December 15th, 2023|

Los Angeles Confronts Alarming Rise in Fentanyl-Related Fatal Overdoses

LOS ANGELES- In an alarming shift in the landscape of substance misuse, fentanyl has emerged as the leading cause of accidental overdose deaths in Los Angeles County, surpassing methamphetamine for the first time. According to a recent report from the L.A. County Department of Public Health, nearly 60% of overdose deaths in the area last ...

December 15th, 2023|

Arkansas’ Cannabis Revenues Generate Substantial Impact on Education and Community Welfare

LOS ANGELES- The newest review from the Arkansas Medical Marijuana Commission (AMMC) reveals the plan of the state's forward move to repurpose a sizeable sum of the revenue from the current upsurge of the state’s cannabis program. The most recent twist in the recent adaptation of fiscal structuring is poised to deliver a nourishing community-wide ...

December 14th, 2023|
Go to Top